Latest news


Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

New Genome Canada funding opportunity

Feb. 14, 2019

Genome Canada launched the Genomics in Society Interdisciplinary Research Teams Program.


More details...

Congratulations to the EpiShare project named in the Global Alliance for Genomics and Health

Feb. 5, 2019

Congratulations to McGill-led EpiShare project, now part of the Global Alliance for Genomics and Health (GA4GH) Driver Project.


More details...

Submission - ministère des Finances du Québec

Feb. 5, 2019

On January 28, 2019, Génome Québec took part in pre-budget consultations led by the ministère des Finances du Québec. 


More details...

Major investments for 11 Québec genomics projects

Feb. 4, 2019

Major federal and provincial investments in the genomics sector were announced today in conjunction with three recent Genome Canada competitions. 


More details...

Passing of Dr. Fernand Labrie

Jan. 21, 2019

Montréal, Monday, January, 21, 2019 – It was with profound sadness that Génome Québec learned of the passing of eminent researcher and physician, Dr. Fernand Labrie. 


More details...

Breast cancer: a simple saliva test to evaluate the risk of developing the disease

Jan. 15, 2019

Génome Québec is pleased to highlight the unprecedented advances of Prof. Jacques Simard’s work, co-author of two important studies on the risk of developing breast cancer.

 

Thanks to this work, a simple saliva test could help to gauge, with unprecedented accuracy, a woman’s risk of developing breast cancer during her lifetime, according to an international study published today. By combining a person’s genetic profile obtained through a saliva sample with a statistical model that takes into account family history, hormonal factors and lifestyle habits, the researchers were able to estimate each woman’s overall risk for breast cancer, paving the way for personalized screening protocols for the disease.


More details...